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Abstract
Purpose: Heart failure is the final common pathway for most forms of heart
disease, and is characterized by a reduced energy status. Myocardial oxygen
consumption (MV02) is closely related to the main determinants of systolic
function (heart rate, pressure and contractility). The aim of the study was to
compare myocardial blood flow, metabolism and mechanical efficiency in rapid
pacing induced heart failure in dogs. Methods: 5 dogs were paced for 3 weeks at
240 bpm, with regular follow up of hemodynamic characteristics. Coronary blood
flow and oxidative metabolism were evaluated with [15O] water and [11C]acetate
clearance respectively, in baseline conditions (B) and after 3 weeks of rapid
pacing (3 wk RP) using positron emission tomography. Results: Three weeks
of rapid pacing in a dog model resulted in a severely depressed left ventricular
function (LV dP/dtmax 3698 ± 314 mmHg (B) vs. 1365 ± 103 mmHg (3 wk RP)).
On the contrary myocardial blood flow 1.29 ± 0.11 ml/min/g (B) vs. 1...
Document type : Article de périodique (Journal article)
Référence bibliographique
De Pauw, Michel ; Melin, Jacques ; De Buyzere, Marc ; Heyndrickx, Guy. Myocardial oxidative
metabolism, blood flow and efficiency in rapid pacing induced heart failure in dogs. In: International
Journal of Physiology, Pathophysiology and Pharmacology, Vol. 6, no. 4, p. 209-215 (2014)
Int J Physiol Pathophysiol Pharmacol 2014;6(4):209-215
www.ijppp.org /ISSN:1944-8171/IJPPP0003459
Original Article
Myocardial oxidative metabolism, blood flow and  
efficiency in rapid pacing induced heart failure in dogs
Michel De Pauw1, Jacques Melin2, Marc De Buyzere1, Guy R Heyndrickx2,3
1Department of Cardiology, Ghent University Hospital, Ghent, Belgium, 2University of Louvain Medical School 
Brussels, Brussels, Belgium, 3Cardiovascular Center Aalst, Aalst, Belgium
Received October 29, 2014; Accepted December 8, 2014; Epub December 15, 2014; Published December 31, 
2014
Abstract: Purpose: Heart failure is the final common pathway for most forms of heart disease, and is characterized 
by a reduced energy status. Myocardial oxygen consumption (MV02) is closely related to the main determinants of 
systolic function (heart rate, pressure and contractility). The aim of the study was to compare myocardial blood flow, 
metabolism and mechanical efficiency in rapid pacing induced heart failure in dogs. Methods: 5 dogs were paced 
for 3 weeks at 240 bpm, with regular follow up of hemodynamic characteristics. Coronary blood flow and oxidative 
metabolism were evaluated with [15O] water and [11C]acetate clearance respectively, in baseline conditions (B) and 
after 3 weeks of  rapid pacing (3 wk RP) using positron emission tomography. Results: Three weeks of rapid pacing 
in a dog model resulted in a severely depressed left ventricular function (LV dP/dtmax 3698 ± 314 mmHg (B) vs. 
1365 ± 103 mmHg (3 wk RP)). On the contrary myocardial blood flow 1.29 ± 0.11 ml/min/g (B) vs. 1.05 ± 0.07 ml/
min/g (3 wk RP) and oxidative metabolism 0.178 ± 0.1 min-1 (B) vs. 0.161 ± 0.1 min-1 (3 wk RP) remained essen-
tially unchanged, indicating a reduced efficiency and a change in O2 utilization. Conclusions: Heart failure induced 
by rapid ventricular pacing in dogs provokes a clearly reduced mechanical efficiency, illustrating the occurrence of 
a metabolic remodeling in heart failure induced by rapid pacing.
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Introduction
The heart is an aerobic organ that relies nearly 
exclusively on aerobic oxidation for the genera-
tion of energy. This explains the close relation-
ship between myocardial oxygen consumption 
(MVO2) and the main determinants of systolic 
function: heart rate, contractile status and wall 
stress [1, 2]. Heart failure is the final common 
pathway for most forms of heart disease, and is 
characterized by a reduced energy status [3-5]. 
Longterm administration of inotropic agents in 
heart failure is detrimental [6], while treatment 
with vasodilating (ACE-inhibitors) and betablo- 
cking agents improves survival, possibly par-
tially due to an energy-sparing effect [7]. This 
concept stresses the interest of mechanical 
efficiency and stimulates the need to study the 
myocardial metabolism in heart failure [8, 9]. 
The model of rapid ventricular pacing in dogs is 
actually a frequently used animal model to 
induce congestive heart failure, and it mimics 
the biochemical and clinical changes seen in 
human congestive heart failure [10, 11]. The 
aim of the study was to compare myocardial bl- 
ood flow, metabolism and mechanical efficien-
cy in baseline conditions and after 3 weeks of 
rapid pacing in conscious dogs. Myocardial en- 
ergetics have been studied in the rapid pacing 
model [12], using pressure-volume relation-
ships and direct measurements of oxygen con-
sumption in isolated heart preparations. This st- 
udy differs, as it was performed in vivo, in clini-
cally more relevant circumstances, evaluating 
each animal in baseline conditions and during 
heart failure using positron emission tomogra-
phy (PET) to measure oxygen consumption and 
myocardial blood flow.
Methods
Chronically instrumented animals
Seven adult mongrel dogs weighing between 
20 and 36 kg underwent surgical instrumenta-
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tion. All animals were sedated with droperidol-
fentanyl (HYPNORM®, Janssen Pharmaceutica), 
and subsequently anesthetized with pentobar-
bital (30 mg/kg IV) (NEMBUTAL®, Janssen Ph- 
armaceutica). A left thoracotomy was perfor- 
med in the fifth intercostal space, the pericar-
dium was incised and the heart exposed. He- 
parin filled silastic catheters were implanted in 
the aorta, left atrium, and the coronary sinus 
(Dow Corning Co., CA). A miniature solid-state 
pressure transducer P7 (Konigsberg Instrumen- 
ts Inc., Pasadena, CA) was implanted in the left 
ventricular cavity through a stab wound in the 
apex. Finally pacing electrodes were sutured to 
the left atrium and to the left anterior wall near 
the apex. All transducer wires and catheters 
were tunnelled subcutaneously to the dorsal 
neck surface. Postoperatively the animals recei- 
ved IV antibiotics  (sulfadoxine - trimethoprim) 
(BORGAL®, Hoechst, GE) for 10 days and were 
allowed to recover from surgery during at least 
two weeks. Animals used in this study were tre- 
ated in accordance with the guidelines of the 
animal ethic committee of the University of Gh- 
ent and with those prepared by the Committee 
on the Care and Use of Laboratory Animals (NIH 
Publication No. 85-23, revised 1996).
Functional and hemodynamic measurements
LV pressure was measured with the implanted 
miniature pressure gauge, which was calibrat-
ed in vitro as well as in vivo during the experi-
ments against systolic arterial pressure mea-
sured in the descending aorta and against dia-
stolic left atrial pressure, both sampled through 
the fluid-filled catheters, and measured with 
Statham P23 ID strain-gauge manometers (Sta- 
tham instruments, Oxnard, CA). The LV press- 
ure derivative (dP/dt) signal was used for timing 
of the cardiac cycle. End-ventricular diastole 
was defined as the beginning of the rise of posi-
tive LV dP/dt, and end-ventricular systole was 
defined at 20 ms before peak negative LV dP/
dt. LV DP40 is defined as the LV dP/dt/pressure 
at a developed pressure of 40 mmHg. The mod-
ified Triple product (TP) is calculated as the 
product of heart rate, systolic arterial pressure 
and LV dP/dtmax and used as an indirect index of 
myocardial oxygen demand [13].
Preparation of radionuclides
[15O] Water was produced by irradiating natural 
oxygen with 28-MeV protons from the Cyclone 
30. The irradiation time was 10 minutes with a 
beam current of 20-35 µA. After bombardment, 
the irradiated gas was transferred to an auto-
matic processing module, in which it was mixed 
with hydrogen in an oven containing 2.5 g pal-
ladium (Pd) wire at 150°C. The Pd-catalyzed re- 
action of oxygen with hydrogen produced the 
[15O] water and natural water vapor that is tra- 
pped by bubbling through sterile isotonic water. 
The nearly quantitative transformation from 
[15O] into [15O] water was realised within 3 min-
utes, filtration through a 0.22-µm Millipore filter 
included. Radionuclide purity was controlled by 
decay curve analysis [14]. 
[11C] Acetate was prepared in a remote contro- 
lled, semi-automated system, using a modifica-
tion of the procedure by Pike [14, 15]. The solu-
tion was sterilized through a 0.22 µm Millipore 
filter. Radiochemical purity, measured by high-
performance liquid chromatography (Aminex 
HPX-87H column, 300x7.8 mm, Biorad, Richm- 
ond, CA, solvent H2SO4 0.008 N, flow rate 0.6 
ml/min, absolute retention time 13.5 min) was 
more than 99%. Specific activity was > 100 Ci/
mmol/l.
Experimental protocol
Hemodynamic measurements 
After complete recovery from surgery a base-
line evaluation was performed. Consequently 
heart failure was induced by rapid ventricular 
pacing (240 bpm) for 3 weeks [10, 11], using a 
homemade stimulator. The presence of heart 
failure signs was determined by both clinical 
signs, such as exercise intolerance, dyspnoe 
and cachexia on the one hand, and hemody-
namic parameters, such as increases in base-
line heart rate and LVEDP, and the decrease of 
LV dP/dtmax on the other hand. The hemodynam-
ic parameters were measured in conscious ani-
mals laying on their right side, in baseline con-
ditions and after 48 hours, 1 week, 2 and 3 
weeks of rapid pacing. All measurements were 
performed in sinus rhythm with the pacemaker 
turned off.
PET studies 
Myocardial perfusion estimates and myocardi-
al substrate metabolism [16-18] were obtained 
with an ECAT III (model 911/01, CTI Inc., 
Knoxville, Tennessee) one ring device, the char-
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acteristics of which have been described previ-
ously [14, 19]. Measurements were performed 
with a stationary ring, and images were recon-
structed with a Hann filter (cutoff frequency, 
0.4 Hz) at a nominal in-plane resolution of 9 
mm full width at half maximum 5FWHM). The 
collimator aperture was set at 30 mm, resulting 
in a slice thickness of 15 mm FWHM. The tomo-
graph was cross-calibrated against a well coun-
ter using a uniform cylindrical phantom (diam-
eter, 20 cm) filled with a solution of 68Ge. 
Transmission scans - needed for attenuation 
correction - were obtained with an external ring 
of 68Ge to confirm proper positioning of the dog 
[19]. 
Tomographic procedures were performed in 
baseline conditions and after 3 weeks of rapid 
pacing in five out of seven instrumented anima- 
ls, with correction of partial volume effect and 
spillover. During the procedure the dogs were 
mildly sedated with propionylpromazine (Com- 
bilen®, Bayer).
Coronary blood flow: Coronary blood flow was 
calculated using the [15O] water perfusion es-
timate.
15 mCi [15O] water was administered as a slow 
bolus over a 30-second period with an infusion 
pump (model 351, Sage Instruments). Thirty se- 
rial cross-sectional images were acquired for 
180 seconds (15 for 2 seconds and 15 for 10 
times, 300 s images 3 times and 600 s images 
2 times depending on residual activity). [11C] 
acetate clearance gives an estimate of the 
overall oxidative metabolism and correlates 
with direct measurement of oxygen consump-
tion using the Fick method, as previously 
described [16, 21, 22]. 
Statistical analysis
Analog signals were recorded on a multichan-
nel tape recorder (HP 3968A) (Hewlett-Packard 
Co., Palo Alto, CA), and were digitised and st- 
ored for processing and statistical analysis 
(SAS 6.03, SAS Institute Inc., Cary, N.C.). Mean 
± SEM values were calculated for all parame-
ters, and differences between responses were 
first tested by the analysis of variance (null 
hypothesis). Differences between responses 
versus control were analysed by the Student’s 
paired t-test. 
Results
Hemodynamic measurements
Following 3 weeks of rapid pacing the animals 
show clear signs of congestive heart failure 
(slower walking, with shortness of breath and 
coughing following exercise). Compared to con-
trol conditions (Figure 1) 3 weeks of rapid pac-
ing induces a significant increase of left ven-
tricular end diastolic pressure, accompanied by 
a significant decrease of left ventricular systolic 
Figure 1. Hemodynamic parameters in control conditions and after 1, 2 
and 3 weeks of rapid pacing. ECG, electrocardiogram; LVP, left ventricular 
pressure; AP, arterial pressure; CBV, coronary blood flow velocity; LV dP/
dt, index of the initial velocity of myocardial contraction.
seconds). [15O] water kinetics 
were calculated using a 2-com-
partment model. The method was 
previously described in detail 
[14].
Oxidative metabolism: Following 
[15O] water acquisition myocardial 
oxidative metabolism was esti-
mated using the [11C] acetate 
clearance [20, 21]. [11C] acetate 
was injected intravenously with a 
pump for 30 seconds. [11C] ace-
tate clearance was measured by 
serial imaging following the IV 
administration of 5-10 mCi of [11C] 
acetate. The turnover rate con-
stant k1 (min-1) was calculated 
using a monoexponential fitting 
(initially 30 s images were acqu- 
ired 6 times followed by 60 s 
images 5 times, 120 s images 6 
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pressure, mean arterial pressure and LV dP/
dtmax as a measure of contractility. Heart rate 
increased slightly but not significantly. Conse- 
quently the modified triple product (TP), an indi-
rect index of myocardial oxygen demand - using 
the product of heart rate, systolic arterial pres-
sure and LV dP/dtmax - was significantly dec- 
reased (Table 1). Significant changes in con-
tractile parameters are already observed fol-
lowing 48 hours of rapid pacing (Figure 2).
PET results
After 3 weeks of rapid pacing myocardial blood 
flow (Table 2) measured with [15O] water dec- 
reased slightly but not significantly from 1.29 ± 
0.11 ml/min/g to 1.05 ± 0.07 ml/min/g, while 
[11C] acetate clearance (Figure 3) decreased sli- 
ghtly but not significantly from 0.178 ± 0.1 min-1 
to 0.161 ± 0.1 min-1. Both parameters did not 
significantly change. This underscores the simi-
lar myocardial perfusion and oxygen consump-
tion after 3 weeks of pacing, compared to base-
line conditions. 
However a work-metabolic index combining the 
modified TP and oxygen consumption (Table 1) 
is significantly altered, indicating an alteration 
of the O2-utilization and a reduced mechanical 
efficiency.
Discussion
Three weeks of rapid pacing in dogs induces a 
significant decrease of left ventricular function, 
with clinical signs indicating congestive heart 
failure. Hemodynamic measurements confirm a 
severely depressed left ventricular function. 
The modified triple product, an indirect param-
Table 1. Hemodynamic parameters at baseline, after 48 hours of rapid pacing (48 h RP), 1 week 
of rapid pacing (1 week RP), 2 weeks of rapid pacing (2 weeks RP) and 3 weeks of rapid pacing (3 
weeks RP)
Baseline 48 h RP 1 week RP 2 weeks RP 3 weeks RP
HR (bpm) 105 ± 9 118 ± 10 115 ± 18 113 ± 14 111 ± 14
LVEDP (mmHg) 11 ± 3 15 ± 4 21 ± 3* 23 ± 1* 22 ± 3*
LVSP (mmHg) 123 ± 4 113 ± 3* 102 ± 4* 102 ± 4* 102 ± 3*
MAP (mmHg) 93 ± 5 89 ± 2 77 ± 5* 76 ± 9* 74 ± 2*
LV dP/dt+ (mmHg/s) 3698 ± 314 2081 ± 157* 1705 ± 105* 1546 ± 113* 1365 ± 103*
LV dP/dt- (mmHg/s) 2685 ± 107 2415 ± 136 1887 ± 165* 1689 ± 119* 1738 ± 63*
LV DP40 65 ± 6 33 ± 3* 26 ± 2* 24 ± 2* 22 ± 3*
Tau (s-1) 18.5 ± 4.2 26 ± 2.7* 31.3 ± 4.7* 36.7 ± 2* 34.7 ± 4.2*
TP (106 x bpm x mmHg2/s) 48.2 ± 7.7 28.2 ± 4.9* 19.9 ± 2.6* 18.1 ± 3.0* 15.5 ± 1.5*
HR, heart rate; LVEDP, left ventricular end-diastolic pressure; LVSP, left ventricular end systolic pressure; MAP, mean arterial 
pressure; LV dP/dtmax, index of the initial velocity of myocardial contraction; LV DP40, LV dP/dt at a developed pressure of 40 
mmHg; Tau, time constant of relaxation; TP, triple product: systolic arterial pressure x heart rate x LV dP/dtmax. Data are mean ± 
standard error of the mean (SEM) *P < .05.
Figure 2. Progressive decrease of contractile functi- 
on, expressed as LV dP/dtmax during 3 weeks of rapid pac-
ing (mean ± sem) (*P < .05).
Table 2. Triple product, [15O] water estimated myo-
cardial blood flow and [11C] acetate clearance in con-
trol conditions and after 3 weeks of rapid ventricular 
pacing 
Control 3 wk RP
TP (106 x bpm x mmHg2/s) 47.4 ± 9.5 19.1 ± 1.9*
MBF (ml/min/g) 1.29 ± 0.11 1.05 ± 0.07
Acetate clearance (k-1, min 
-1) 0.178 ± 0.10 0.161 ± 0.10
TP, triple product: systolic arterial pressure x heart rate x LV dP/
dtmax as indirect index of myocardial oxygen demand; MBF, [
15O] 
water estimated myocardial blood flow; k-1, the turnover rate con-
stant using a mono-exponential fitting from the 1-[11C] acetate 
clearance curve; 3 wk RP, 3 weeks of rapid pacing at 240 bpm. 
Data are mean ± standard error of the mean (SEM) *P < .05.
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eter of myocardial O2 demand and work per-
formed, and closely related to the main deter-
minants of systolic function, is significantly 
decreased. We deliberately used a modified 
calculation of the triple product, in which for-
mula the left ventricular ejection time was ex- 
changed for the LV dP/dtmax, in order to have a 
more powerful impact of the contractile status 
of the myocardium.
In contrast to the clearly reduced contractile 
status, the myocardial blood flow, calculated wi- 
th [15O] water is preserved and the [11C] acetate 
decay measurements - a measure for the over-
all myocardial oxidative metabolism - are unch- 
anged. These findings indicate that while flow 
and oxidative metabolism are preserved the 
mechanical work is severely reduced, confirm 
earlier in vitro findings in this model using iso-
lated hearts [12], and clearly illustrate a redu- 
ced mechanical efficiency, suggesting a shift of 
the O2-utilization in this rapid pacing model of 
heart failure to other energy consuming pro-
cesses in the myocardial cells, i.e. basal metab-
olism and excitation-contraction coupling [8]. 
These data also confirm the decrease of me- 
chanical efficiency and the clear metabolic re- 
modeling observed in human dilated cardiomy-
opathy and underscore the hypothesis that an 
increased energy expenditure relative to work 
is present in heart failure and may also contrib-
ute to the progression of the disease [3-5]. It 
was shown that drugs which provoke an oxygen 
sparing effect in heart failure (ACE inhibitors, 
beta-blocking agents) not only have a positive 
effect on LV function but also on survival [7, 8], 
while on the contrary positive inotropic drugs 
[6, 21, 22] which increase the energetic cost 
provoke an acute enhancement of LV function 
but with a detrimental effect on survival and 
induce an oxygen wasting at the cellular level. 
More recently cardiac resynchronisation thera-
py was also proven not only to have a positive 
effect on myocardial function, but also on sur-
vival, which was again associated with an inc- 
rease of mechanical efficiency [24-29]. These 
observations should stimulate to study more 
carefully energetics during the evaluation of 
new therapeutic strategies in heart failure, as 
the effect on energetics appears to be cardinal 
for the impact of treatment on survival. 
In addition in this animal model clear changes 
in the hemodynamic profile are already obse- 
rved after 48 hours of rapid pacing, as illustrat-
ed by the early significant decrease of contrac-
tile function and the triple product. These obse- 
rvations suggest the early occurrence of major 
changes at the myocardial and cellular level, 
which may trigger the evolution unto heart fail-
ure. Therefore the focus of future work in this 
model should be deflected to the elucidation of 
the mechanism of these early changes at the 
cellular level.
Figure 3. Selected PET images after [11C] acetate injection in the same dog in control conditions (Control) and after 
3 weeks of rapid pacing (RP). Radioactivity is color coded, with the highest activity in red and the lowest in dark blue.
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